Multiple sclerosis and immune-reset transplantation

Category: Conditions & evidence · Editorial Review: Updated 20 October 2026 · 3 minute read

Two very different ideas

In multiple sclerosis, autologous hematopoietic stem cell transplantation is studied and used in selected specialist settings to rebuild the immune system after intensive immune treatment. Its aim is not simply to inject cells that turn into new nerves. Commercial mesenchymal-cell or wellness infusions should not borrow the evidence for this distinct transplant pathway.

Selection is central

The type of MS, recent inflammatory activity, disability history and response to disease-modifying medicines matter. A neurologist and transplant team must weigh possible benefit against conditioning risks. NIH research compares the transplant strategy with strong available medical treatment in selected relapsing disease. Results cannot automatically be generalized to every person with progressive disability.

What to ask in a consultation

Ask whether the goal is to reduce new inflammatory disease activity, prevent disability progression or improve existing symptoms. These are different outcomes. Request a discussion of nontransplant treatment options and how the center assesses candidacy. Clarify whether the offered intervention is a formal transplant program or a different cell procedure with a different evidence base.

Prepare for long-term follow-up

Bring MRI reports and images, relapse dates, disability assessments and a complete history of disease-modifying therapy. Discuss infection prevention, fertility, rehabilitation and the plan for neurological monitoring after returning home. Do not stop your MS medicines before a specialist has agreed on the treatment sequence and any required transition period.

Continue exploring

• Acute myeloid leukemia and transplantation
• Acute lymphoblastic leukemia and transplantation
• Multiple myeloma and autologous transplant
• Prepare your consultation checklist

Sources & further reading

• Primary patient information and research

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.